We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Future Virtual Colonoscopy Could Be Laxative-Free

By HospiMedica International staff writers
Posted on 20 Jun 2012
Sophisticated computer software is being used to make stool in the colon disappear during computed tomographic colonography (CTC), similar to “photoshopping” blemishes from still photos.

Researchers at Massachusetts General Hospital (MGH, Boston, USA) recruited 605 volunteers at four medical centers, including MGH and nearby Brigham and Women’s Hospital (BWH, Boston, MA, USA) for a prospective evaluation of laxative-free CTC compared to optical colonoscopy (OC). More...
The CTC included electronic cleansing and computer-aided detection.

Optical colonoscopy examinations were initially blinded to CTC results, which were subsequently revealed during colonoscope withdrawal. For two days before the CTC scans, the volunteers drank small amounts of a contrast agent with their meals, which chemically tagged the stool, allowing the software to detect it and subtract it from the computerized tomography (CT) scan.

The laxative-free CTC method was accurate in detecting adenomas 10 mm or larger in 91% of the patients with precancerous polyps, but was less accurate for smaller lesions. Patient experience was better with laxative-free CTC, which is about as accurate as conventional colonoscopy. According to the researchers, these results suggest a possible role for laxative-free CTC as an alternate screening method. The study was published in the May 15, 2012, issue of Annals of Internal Medicine.

“The trouble is a lot of the people at risk of colorectal cancer have a strong aversion to the laxative prep that is required for colonoscopy,” said lead author Michael Zalis, MD, an associate professor of radiology at MGH and director of CTC. “Laxative-free CT colonography has the potential to reach some of the unscreened population and save lives.”

CTC is an imaging procedure that produces images of the colon from the rectum, all the way to the cecum, and provides 3D reconstructed endoluminal views of the bowel. The procedure is used to diagnose colon and bowel disease, including polyps, diverticulosis, and cancer. The main disadvantage to CTC is that a radiologist cannot remove polyps, so a conventional colonoscopy must be performed if abnormalities are found. Also, it does not show as much detail as a conventional colonoscopy, so polyps smaller than 2-10 millimeters in diameter may not show up on the images.

Related Links:
Massachusetts General Hospital
Brigham and Women’s Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.